July 24, 2014 1:17 AM ET

Company Overview of The Multiple Myeloma Research Foundation, Inc

Company Overview

,  

United States

Founded in 1998

Key Executives for The Multiple Myeloma Research Foundation, Inc

Chief Executive Officer
Age: 49
Founder and Executive Chairman
Age: 55
Founder
Age: 59
Chief Medical Officer and Chief Medical Officer of Multiple Myeloma Research Consortium
Age: 54
Vice President of Communications
Compensation as of Fiscal Year 2014.

The Multiple Myeloma Research Foundation, Inc Key Developments

Multiple Myeloma Research Foundation Announces Management Changes

The Multiple Myeloma Research Foundation (MMRF) announced that Kathy Giusti, Founder and CEO of the MMRF and the Multiple Myeloma Research Consortium (MMRC), will become the Executive Chairman of the MMRF Board of Directors. Dana LaForge, who served as Board Chairman for ten years, will continue to serve on the MMRF Board. Walter Capone will assume the role of President and Chief Executive Officer, reporting to Kathy Giusti.

The Multiple Myeloma Research Foundation, Inc Presents at The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum, Mar-19-2014 05:00 PM

The Multiple Myeloma Research Foundation, Inc Presents at The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum, Mar-19-2014 05:00 PM. Venue: New York Academy of Sciences, New York, United States. Speakers: Walter M. Capone, Chief Operating Officer.

The Multiple Myeloma Research Foundation Promotes Walter Capone to President

The Multiple Myeloma Research Foundation (MMRF) announced the promotion of Walter M. Capone from Chief Operating Officer to President of the MMRF, effective on December 16, 2013. In his new role Mr. Capone will assume full responsibility for the organization and its operations. He will report directly to Kathy Giusti, MMRF Founder and CEO. joining the MMRF, he served as Vice President of Commercial Development and Operations at Progenics Pharmaceuticals working with their global partner Wyeth/Pfizer to commercialize the company's first approved drug, RELISTOR(R).

Similar Private Companies By Industry

Company Name Region
University Of Iowa Research Foundation United States
FeeX-Robin Hood of Fees United States
Concord Lumber Corporation United States
SW Border Incineration, LLC United States
SidePlate Systems Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact The Multiple Myeloma Research Foundation, Inc, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.